title: Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
abstract: Head injury and apolipoprotein E (APOE)-epsilon 4 (e4) genotype have each been associated with increased risk of Alzheimer's disease. If APOE-e4 affects neuronal viability and branching, and if response to head injury differs in e4 patients, then the association between head injury and Alzheimer's disease may vary with the presence of the e4 allele. The authors examined this association in a case-control study conducted between 1987 and 1995 among enrollees of the Group Health Cooperative of Puget Sound, a health maintenance organization in Seattle, Washington. Proxy informants reported prior head injury with loss of consciousness for 32 of 349 patients with probable Alzheimer's disease and for 16 of 342 control subjects of similar age and sex who had been randomly selected from the same population (odds ratio (OR) = 2.1, 95% confidence interval (CI) 1.1-3.8). Elevated risk was observed among men (OR = 4.2, 95% CI 1.5-11.5) but not among women (OR = 1.1, 95% CI 0.5-2.6). No significant variation in the head injury-Alzheimer's disease risk relation by APOE-e4 genotype was found among 230 cases and 309 controls (OR = 3.1 (95% CI 0.7-14.6) for persons with at least one e4 allele and OR = 2.0 (95% CI 0.8-5.2) for those without e4). Neither age, education, race, type of proxy informant, nor duration of relationship with the proxy confounded the association. Head injury with loss of consciousness, although uncommon in this sample, was associated with increased risk of Alzheimer's disease. APOE-e4 was an independent risk factor which neither modified nor confounded the association. Susceptibility to Alzheimer's disease as conferred by APOE-e4 does not appear to increase the risk associated with head injury.
authors.affiliation: Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle 98195, USA.
authors.forename: E S
authors.initials: ES
authors.lastname: O'Meara
authors.forename: W A
authors.initials: WA
authors.lastname: Kukull
authors.forename: L
authors.initials: L
authors.lastname: Sheppard
authors.forename: J D
authors.initials: JD
authors.lastname: Bowen
authors.forename: W C
authors.initials: WC
authors.lastname: McCormick
authors.forename: L
authors.initials: L
authors.lastname: Teri
authors.forename: M
authors.initials: M
authors.lastname: Pfanschmidt
authors.forename: J D
authors.initials: JD
authors.lastname: Thompson
authors.forename: G D
authors.initials: GD
authors.lastname: Schellenberg
authors.forename: E B
authors.initials: EB
authors.lastname: Larson
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics; D001057:Apolipoproteins E / Q000097:blood* / Q000235:genetics*; D006259:Craniocerebral Trauma / Q000150:complications* / Q000453:epidemiology; D005260:Female; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D012306:Risk; D012307:Risk Factors; D014474:Unconsciousness; D014861:Washington / Q000453:epidemiology
chemical_list: D001057:Apolipoproteins E